Vivos Therapeutics soars as FDA clears sleep apnea device

Vivos Therapeutics

04/01/2023 17:05

(Updates)
    ** Shares of medical device maker Vivos Therapeutics Inc 
 VVOS.O  more than triple to $2.55
    ** Stock records biggest-ever one-day pct gain
    ** U.S. FDA clears the use of VVOS' device to treat
mild-to-moderate obstructive sleep apnea (OSA)
    ** OSA is the most common sleep-related breathing disorder,
which occurs when throat muscles intermittently relax and block
the airway during sleep
    ** Company's shares down nearly 70% in the past 12 months
 (Reporting by Mariam E Sunny)
 ((Mariam.ESunny@thomsonreuters.com))